Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Novartis and Sandoz Recall Non-Compliant Blister Packs

The prescription drugs were not in child resistant packaging, which put them in violation of the Poison Prevention Packaging Act.

Recalled Packaging
Recalled Packaging

A recent article from The Columbus Dispatch noted the recall of 9 different drugs from Sandoz and Novartis. Apparently both companies were in violation of the Poison Prevention Packaging Act, as their drugs were not properly packaged in child resistant blister packs. The oversight led to a confirmed report of a child ingesting haloperidol from a blister pack.

The recall affects lots sold at clinics and pharmacies nationwide between September 2016 and June 2018. Consumers with affected lots are instructed to secure the blister cards to keep them away from children and contact the companies for further instructions. The affected drugs include: Azithromycin, Donepezil, Haloperidol, Imipramine HCl, Isosorbide Dinitrate, Naratriptan, Ondansetron, Perphenazine, and Risperidone.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?